Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Carcinoma, Hepatocellular × Hepatectomy × Clear all

Phase

Phase NA 13 Phase 4 4 Phase 3 3 Phase 2 3 Phase 2/3 2 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 1

Interventions

Sorafenib 26 Nivolumab 21 pembrolizumab 15 Bevacizumab 15 lenvatinib 12 atezolizumab 10 Cyclophosphamide 9 Ipilimumab 8 durvalumab 6 camrelizumab 5 apatinib 5 Specimen Handling 5 Radiosurgery 5 tislelizumab 4 fludarabine 4 Immunotherapy, Adoptive 4 Fluorouracil 4 Doxorubicin 4 tremelimumab 3 toripalimab 3 sintilimab 3 regorafenib 3 cabozantinib 3 X-Rays 3 Magnetic Resonance Spectroscopy 3 Injections 3 Everolimus 3 Ethiodized Oil 3 Erlotinib Hydrochloride 3 tepotinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00845689 2009-02-18

LTR

Ludwig-Maximilians - University of Munich

Phase 1/2 Unknown

Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡